Continue to Site

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » FDA approves spine sealant from Covidien | Regulatory roundup

FDA approves spine sealant from Covidien | Regulatory roundup

By

Clearances roundup

Here’s a roundup of companies announcing clearances and approvals from the FDA and foreign regulatory agencies. Check out MassDevice’s compilation of the latest regulatory news for additional clearances and approvals.

  • FDA approves spine sealant from Covidien
    Covidien plc (NYSE:COV) announced that its DuraSeal Exact spine sealant has been approved by the FDA (FDA). DuraSeal Exact spine sealant is a new, low-swell formulation of dural sealant designed as an adjunct to suturing to repair the dura during spine surgery. The dura mater, or dura, encompasses the three layers of the meninges surrounding the spinal cord that protect and hold cerebrospinal fluid.
    Read more

  • Hitachi Medical Systems America wins FDA clearance for its SCENARIA CT system
    Hitachi Medical Systems America Inc., a provider of diagnostic imaging equipment, announced FDA clearance to market its SCENARIA CT system, the latest in the company’s line of CT products. SCENARIA combines the latest dose saving technologies in a new 64-slice platform that meets today’s need for a CT system that provides both routine and advanced applications with enhanced performance and value.
    Read more

  • Delcath wins CE Mark for Hepatic Chemostat system
    Delcath Systems Inc. (NSDQ:DCTH) announced that the Company has been notified of CE Mark approval for its proprietary Hepatic CHEMOSATTM Delivery System. The product has been approved with an indication for the percutaneous intra-arterial administration of a chemotherapeutic agent (melphalan hydrochloride) to the liver.
    Read more

  • Asante receives CE Mark for Pearl insulin pump
    Asante Solutions Inc., a medical device company focused on diabetes care, announced it received the CE mark for its Pearl Insulin Pump, the only insulin pump that uses a pre-filled insulin cartridge. The CE mark is a European proof of conformity that certifies the product meets EU safety, health and environmental requirements. Asante has begun discussions with potential distribution partners in Europe.
    Read more

  • ARTAS receives FDA clearance for hair loss treatment
    Restoration Robotics Inc. a privately-held medical device company, announced that its revolutionary technology, the ARTAS System, has received 510K clearance from the FDA for harvesting hair follicles from the scalp in men diagnosed with androgenetic alopecia (male pattern hair loss) with black or brown straight hair.
    Read more

  • St. Jude Medical wins approval for ShockGuard technology
    St. Jude Medical Inc. (NYSE:STJ), a global medical device company, announced that it has received FDA and European CE mark approval of its ShockGuard technology. The technology, which can be used with new and existing Unify cardiac resynchronization therapy defibrillators (CRT-Ds) and Fortify implantable cardioverter defibrillators (ICDs), is designed to reduce inappropriate and unnecessary shocks for patients with these devices.
    Read more

  • GE Healthcare receives FDA clearance of GEM suite for MRI
    GE Healthcare announced FDA clearance of the GEM Suite (Geometry Embracing Method) of surface coils designed for use with the Optima* MR450w 1.5T wide bore magnetic resonance imaging system, offering excellent patient comfort without clinical compromise. GEM Suite helps technologists reposition patients less often and cover more anatomy; provides radiologists more clinical options; and can give administrators more efficiency through higher throughput and system utilization.
    Read more

  • ThermoGenesis announces registration of Res-Q in India
    ThermoGenesis Corp. (NSDQ:KOOL), a supplier of innovative products and services that process and store adult stem cells, said that its Res-Q60 BMC System (Res-Q) has been registered by the Central Drugs Standard Control Organization of India (CDSCO), allowing its commercial sale in the country. Res-Q is a point of care system used for the preparation of cell concentrates, including stem cells from bone marrow aspirate.
    Read more

  • XDx announces that AlloMap wins CE Mark
    XDx Inc., a molecular diagnostics company focused on developing and commercializing innovative, noninvasive gene expression tests to monitor immune-mediated conditions, announced that its AlloMap Molecular Expression Test has been CE marked in the European Union (EU) under the In Vitro Diagnostics Directive.
    Read more

  • Medyssey Spine wins Clearance for LP Cage
    Medyssey Co., Ltd., the parent company of Medyssey Spine, a spinal implant manufacturer focused on commercializing products for the surgical treatment of spine disorders, announced that the Company has received 510(k) clearance from the FDA for its LP Cage indicated for use in skeletally mature patients with Degenerative Disc Disease at one or two contiguous levels from L2-S1 from a posterior approach for lumbar interbody fusion. The product is currently in limited, controlled release and is targeted for full commercial launch by Q4 2011.
    Read more

  • Devon wins clearance for ArterioFlow
    Devon Medical Products, a manufacturer and distributor of creative, safe, and cost-effective medical devices, announced it received FDA 510(k) clearance to market its ArterioFlow 7500 arterial pump that treats diabetic foot ulcers, peripheral arterial disease, and other chronic disorders of the lower extremities caused by reduced blood supply or ischemia.
    Read more

  • Integra LifeSciences wins slearance for new indication for Accell Evo3
    Integra LifeSciences Holdings Corporation (NSDQ:IART) announced that it has received 510(k) clearance from the United States FDA to market Accell Evo3 Demineralized Bone Matrix as a bone void filler product for use in the posterolateral spine.
    Read more

  • Aethlon Medical announces multi-target exosome assay validation
    Aethlon Medical Inc. (OTC:AEMD) announced that its wholly owned subsidiary Exosome Sciences Inc. (ESI) has validated the ability of its Enzyme Linked Lectin Specific Assay (ELLSA) to identify the presence of exosomes underlying the human immunodeficiency virus (HIV), tuberculosis (TB), and various forms of cancer, including ovarian, melanoma, breast, lymphoma, and colorectal.
    Read more

  • SurgiVision MRI-compatible SmartFlow cannula receives FDA clearance
    SurgiVision Inc., a leader in interventional MRI-guided systems, announced at the American Association of Neurological Surgeons (AANS) annual meeting that its SmartFlow neuro ventricular cannula has received FDA clearance.
    Read more

  • Cepheid wins clearance for Xpert Clostridium difficile/Epi
    Cepheid (NSDQ:CPHD) announced that it has received clearance from the FDA to market its Xpert C. difficile/Epi test. Cepheid’s first Xpert C. difficile test has been available in the United States since July 2009. The test’s unique combination of high sensitivity and rapid turnaround time has quickly established Xpert C. difficile as the molecular market leader. Building on the success of Xpert C. difficile, which detects the bacterium that causes C. difficile infection (CDI), Xpert C. difficile/Epi additionally and simultaneously identifies the epidemic strain of C. difficile, also known as 027, NAP1 or BI.
    Read more

  • FDA clears single-use antibacterial surgical respirator
    The FDA cleared the SpectraShield 9500 N95 surgical respirator, a device that kills 99.99 percent of three different kinds of bacteria when exposed to its outer surface.
    Read more

  • Integra receives FDA clearances for three spinal fixation devices
    Integra LifeSciences Holdings Corporation (NSDQ:IART) announced that it has received 510k clearance from the United States FDA for three new spinal intervertebral body fusion devices (IBD), continuing to build its momentum in the spine market.
    Read more

  • GenesisPlus receives FDA clearance for Onychomycosis
    Cutera Inc. (NSDQ:CUTR), a worldwide provider of laser and light-based aesthetic systems for practitioners worldwide, announced FDA 510(k) clearance for its GenesisPlus. The complete list of the indications for use can be found in the FDA 510(k) clearance number (K) 103626.
    Read more

  • superDimension receives FDA 510(k) clearance for marker delivery kit
    superDimension Ltd., a privately-owned company that develops minimally invasive interventional pulmonology devices, announced it has received FDA 510(k) clearance for the superDimension marker delivery kit. The kit is designed for use with the Company’s Electromagnetic Navigational Bronchoscopy (ENB) system, which has treated a total of 20,000 total patients since commercial launch.
    Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • New results detail J&J Embotrap design’s first-pass performance in stroke patients
    Johnson & Johnson (NYSE:JNJ) has released results for its Embotrap stent retrievers showing the next-generation design’s success in removing blood clots from ischemic stroke patients. Johnson & Johnson MedTech’s Cerenovus subsidiary tracked outcomes for 1,000 ischemic stroke patients who underwent mechanical thrombectomy procedures with Embotrap devices as a first-line therapy. “The positive preliminary findings of… […]
  • Cardinal Health expands single-use device reprocessing facility
    Cardinal Health (NYSE:CAH) recently opened its expanded Sustainable Technologies facility in Riverview, Florida. The facility is now twice as large as before, at 100,000 square feet, said Dublin, Ohio-based Cardinal Health. The medical device manufacturer and distributor launched Sustainable Technologies in 2015 to collect, reprocess and recycle single-use devices in the U.S. Sustainable Technologies now… […]
  • A new mechanically active adhesive fights muscle atrophy
    Harvard bioengineers have created a mechanically active adhesive that can prevent muscle wasting and support atrophy recovery. They call it MAGENTA, an acronym for mechanically active gel–elastomer–nitinol tissue adhesive. Researchers from the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School of Engineering and Applied Sciences successfully tested… […]
  • November 2022 Issue: 2022 Medical Device Handbook
      Medtronic, Abbott and ResMed see healthcare improving through ecosystems DermaSensor aims to expand access to accurate skin cancer detection How J&J’s Embotrap stent retriever thrombectomy treats ischemic strokes Design challenges to overcome when developing cardiac ablation devices How Medtronic designed the next generation of GI bleeding treatment Innovate together Medical devices have never been… […]
  • Could minimally invasive neuromod tackle the opioid epidemic?
    Officials at Spark Biomedical and AcuityMD think their partnership could accelerate the commercialization of Spark’s potentially game-changing platform. Spark Biomedical develops a topical, minimally invasive medical device for alleviating opioid withdrawal symptoms. AcuityMD has a platform for helping medical device companies accelerate commercial access to their products. Together, they seek to provide a pathway to… […]
  • BMP Medical appoints Michael Carignan as programs and engineering manager
    BMP Medical announced that it appointed Michael Carignan as its new programs and engineering manager. Carignan joins BMP Medical at its Sterling, Massachusetts plastic manufacturing hub facility. He brings with him more than 33 years of experience in the plastic manufacturing industry. Before BMP Medical, Carignan served as president of Wachusett Precision Tool for more… […]
  • PTI Engineered Plastics receives MedAccred plastics accreditation
    PTI Engineered Plastics recently announced that MedAccred has recognized it for its commitment to continual improvement in medical device quality. The Macomb, Michigan–based company’s MedAccred accreditation follows a successful audit. MedAccred found that the medical device contract manufacturer demonstrated an ongoing commitment to quality by satisfying customer requirements and industry specifications. The nonprofit Performance Review… […]
  • Millstone Medical Outsourcing buys MycoScience
    Millstone Medical Outsourcing has purchased MycoScience, the companies said today. Fall River, Massachusetts-based Millstone said it closed the deal on Nov. 14. Terms were not disclosed. Willington, Connecticut-based MycoScience is an ISO 13485 certified contract manufacturing organization operating out of an FDA-registered facility. The company has more than three decades of experience in medical device… […]
  • These 14 medical device inventions are the best, Time magazine says
    Fourteen medical devices ranging from patient monitoring to surgical robotics recently made it into Time magazine’s Best Inventions of 2022. For over 20 years, Time magazine has highlighted the 100 most impactful devices and ideas around the world. The list is compiled through nominations from the publication’s editors and global correspondents, with special attention to… […]
  • Why Affera’s cardiac ablation technology is worth $1B to Medtronic
    Affera started in 2014 with a simple goal that paid off when Medtronic (NYSE:MDT) bought the company for up to $1 billion this year. Achieving that goal, however, took some unconventional and sometimes difficult design choices, Affera founder and CEO Doron Harlev said. Newton, Massachusetts–based Affera’s system diagnoses, maps and treats heart arrhythmias with ablation.… […]
  • Viant expands Design & Development West Center of Excellence in California
    Viant today said it has completed the expansion of its Design & Development West Center of Excellence in Fremont, California. The facility’s footprint is now 67% larger, totaling 25,000 sf² across two buildings co-located with the company’s complex molding and assembly facility. The expansion triples the amount of ISO 8 and ISO 7 cleanroom space… […]

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy